Nucleic Acids Research, 1990, Vol. 18, No. 1 1-11
© 1990
ENZYMOLOGY |
Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats
Department of Molecular Genetics, The Ohio State University Columbus, OH 43210, USA
* To whom correspondence should be addressed
Received December 6, 1988. Accepted August 1, 1989.
Alternating purine-pyrimidine sequences (RY repeats) demonstrate considerable homology to the consensus sequence for vertebrate topoisomerase II (Spitzner and Muller (1988) Nucleic Acids Res. 16: 1533–1556). This is shown below and positions that can match are underscored.
(R is purine, Y is pyrimidine, K is G or T.) Topoisomerase II cleavage reactions were performed (in the absence of inhibitors) on a plasmid containing a 54 base RY repeat and the single strong cleavage site mapped to the RY repeat. Analysis of this DNA on sequencing gels showed that the enzyme cleaved a number of sites, all within the 54 base pair RY repeat. Topoisomerase II also made clustered cleavages within other RY repeats that were examined. Quantitative analysis of homology to the consensus sequence, as measured by the match of a site to a matrix of base proportions from the consensus data base (the matrix mean), showed that both the locations and the frequencies of cleavage sites within RY repeats were proportional to homology scores. However, topoisomerase II cleaved RY repeats preferentially in comparison to non-RY sites with similar homology scores. The activity of the enzyme at RY repeats appears to be proportional to the length of the repeat; additionally, GT, AC and AT repeats were better substrates for cleavage than GC repeats.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Toyoda, S. Kagaya, I. G. Cowell, A. Kurosawa, K. Kamoshita, K. Nishikawa, S. Iiizumi, H. Koyama, C. A. Austin, and N. Adachi NK314, a Topoisomerase II Inhibitor That Specifically Targets the {alpha} Isoform J. Biol. Chem., August 29, 2008; 283(35): 23711 - 23720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Mueller-Planitz and D. Herschlag DNA topoisomerase II selects DNA cleavage sites based on reactivity rather than binding affinity Nucleic Acids Res., June 28, 2007; 35(11): 3764 - 3773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Duca, D. Guianvarc'h, K. Oussedik, L. Halby, A. Garbesi, D. Dauzonne, C. Monneret, N. Osheroff, C. Giovannangeli, and P. B. Arimondo Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides. Nucleic Acids Res., January 1, 2006; 34(6): 1900 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gao, E. F. Yamasaki, K. K. Chan, L. L. Shen, and R. M. Snapka DNA Sequence Specificity for Topoisomerase II Poisoning by the Quinoxaline Anticancer Drugs XK469 and CQS Mol. Pharmacol., June 1, 2003; 63(6): 1382 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Mizushina, C. Murakami, H. Takikawa, N. Kasai, X. Xu, K. Mori, M. Oshige, T. Yamaguchi, M. Saneyoshi, N. Shimazaki, et al. Molecular Action Mode of Hippospongic Acid A, an Inhibitor of Gastrulation of Starfish Embryos J. Biochem., April 1, 2003; 133(4): 541 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eguchi-Ishimae, M. Eguchi, E. Ishii, S. Miyazaki, K. Ueda, N. Kamada, and S. Mizutani Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals Blood, February 1, 2001; 97(3): 737 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Burden and N. Osheroff In Vitro Evolution of Preferred Topoisomerase II DNA Cleavage Sites J. Biol. Chem., February 19, 1999; 274(8): 5227 - 5235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Spitzner, I. K. Chung, and M. T. Muller Determination of 5` and 3` DNA Triplex Interference Boundaries Reveals the Core DNA Binding Sequence for Topoisomerase II J. Biol. Chem., March 17, 1995; 270(11): 5932 - 5943. [Abstract] [Full Text] [PDF]
|
|